NIH, OPM, Acquisitions Branch A, EPS, Rm 801, Rockville, Maryland 20892-7260

Q -- PERFORM ASSAYS FOR THE THE D4 DOPAMINE RECEPTOR SOL 263-96-P-(BL)-0027 POC Christopher Belt, Contract Specialist, Ph: (301) 402-3067, Fax: (30) 402-3406/7. The National Institutes of Health intends to procure on a sole source basis to Perimmune, Inc., 1330 Piccard Drive, Rockville, Maryland, 20850-4396 for providing the Government with data on the specific DRD4 genotypes of Baltimore Longitudinal Study of Aging (BLSA) participants. The period of performance will be for one (1) twelve month period with options to renew for three (3) additional one-year periods. Specifically, the contractor shall perform 1,000 assays for the D4 dopamine receptor (DRD4) gene on DNA from participants in the Baltimore Longitudinal Study of Aging (BLSA). It is believed that Perimmune, Inc. is the sole-source for this requirement under the authority of FAR 6.302-1 because of the following: Specific biochemical and molecular genetic assays must be performed in order to determine the DRD4 genotype. Perimmune has extracted the needed DNA from BLSA participants for the apoE assay that they are performing under current contract. (0185)

Loren Data Corp. http://www.ld.com (SYN# 0076 19960705\Q-0001.SOL)